Tag Archives: More

Why Sage Therapeutics CEO Jeff Jonas believes Zulresso will remedy more than postpartum depression

In late June the 400,000 women in the U.S. affected each year with postpartum depression will no longer be forced to endure the extreme sadness, anxiety, exhaustion and other symptoms that define this debilitating, often misunderstood condition. That’s because that’s when Zulresso, the first and only medicine approved by the Food and Drug Administration to… Read More »

Peanut allergy immunotherapy may actually do more harm than good

Food allergies are on the risePicture Partners/Alamy By Sam Wong For people with peanut allergies, undergoing immunotherapy may actually increase their risk of having allergic or anaphylactic reactions. Immunotherapy is an experimental treatment for allergies that involves repeated exposure to the allergen in gradually increasing doses, aiming to desensitise the patient’s immune system. To get… Read More »

HMS researchers design algorithm that ID’s DNA defects, making more cancers treatable

Medications known as PARP inhibitors have emerged as a promising therapy for several forms of cancer fueled by a defect in the cells’ DNA repair machinery. Yet many people with cancers caused by the defect, known as HR deficiency, who stand to benefit from PARP inhibitors remain unidentified because standard genetic panels used in the… Read More »